x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Joint Action

David Hunter, PhD, FRACP (Rheum)

Joint Action is a podcast hosted by David Hunter.As a consequence of isolation, those living with osteoarthritis related disability may become less fit, more depressed and anxious, more socially isolated and gain weight. It is critical at times like this that people with osteoarthritis have their burden and disability minimised and their knowledge of how to manage the disease enhanced. Join David as he interviews the world"s leading experts in osteoarthritis.Professor David Hunter is a rheumatology

health & fitness medicine

All Episodes

31:55

The burden of osteoarthritis with Prof Gillian Hawker

Joint Action ·

2021/04/18

The impact of osteoarthritis remains a major challenge for healthcare systems worldwide with approximately 528 million people affected. The global prevalence of hip and knee OA is approaching 5% and expected to increase further with the aging population. The increasing rates of obesity in adults, combined with lack of physical activity and joint injuries are also contributing to the rise in OA incidence. Osteoarthritis is a serious condition which has substantial implications on one’s day-to-day

en

42:40

Sex and gender differences in osteoarthritis with Dr...

Joint Action ·

2021/04/04

Osteoarthritis places a large burden on the individuals that are affected as well is to society as a whole. It is important to reflect that that burden is not distributed equally. The prevalence of osteoarthritis is higher amongst women compared to men. Women also experience higher rates of disease severity and disability. In an effort to better understand these disparities with the overarching focus being to improve health outcomes for all it is important to understand the influence of sex and

en

31:33

New insights into osteoarthritis onset with Prof...

Joint Action ·

2021/03/21

Despite the large prevalence of osteoarthritis, there is no clinically approved drug which provides a cure. Currently, drugs focus on relieving symptoms such as pain. Experiments done in the laboratory have provided insight on osteoarthritis onset and progression and will likely guide therapeutic development. We know that osteoarthritis is a disease of the whole organ meaning that any of the tissues involved in the synovial joint can be affected. The interplay between the various cell types involved

en

33:42

What type of osteoarthritis do I have? with Prof...

Joint Action ·

2021/03/07

There are many reasons why osteoarthritis (OA) might develop in the first place, the progression of the disease can vary dramatically between different individuals and their response to different treatments can similarly be quite distinct. With the greater understanding OA pathophysiology, OA can often be described as a spectrum of disease composed of different phenotypes. Some people have even described this as a mixed bag of disorders or falling under the osteoarthritis umbrella. By characterising

en

33:33

Osteoarthritis flares with Dr Martin Thomas

Joint Action ·

2021/02/21

Like other chronic conditions, the symptoms of osteoarthritis tend to fluctuate. About 25-30% of people suffering from knee osteoarthritis also suffer from what we call OA “flares” or “exacerbations”. These “flares” are often described as temporary episodes of increased pain, stiffness and swelling, which may also be accompanied by other physical and psychological symptoms. “Flares” can cause considerable disruption to daily activities, sleeping and concentration and is a common complaint from those

en

1:51

A message from David

Joint Action ·

2020/12/13

Thank you all for your support this year. Please remember to give us a review on the Apple Podcasts page and leave a review :) Wishing everyone has a happy and healthy holiday season and new year! CONNECT WITH USTwitter: @ProfDavidHunter @jointactionorgEmail: hello@jointaction.infoWebsite: www.jointaction.info/podcast Hosted on Acast. See acast.com/privacy for more information.

en

50:01

Common misconceptions about osteoarthritis with Tonia...

Joint Action ·

2020/12/06

Despite the prevalence, impact and disability associated with osteoarthritis, it is still relatively poorly understood. New insights are affording a window into previously held strong beliefs that we now consider as misconceptions. Many people in the community simply believe that osteoarthritis is a consequence of getting older. Others believe that the joint has no capacity for repair and some have suggested that we should just use treatments widely used for other inflammatory rheumatic diseases

en

40:17

What should I expect from my GP? with Regina Sit and...

Joint Action ·

2020/11/29

Osteoarthritis is a frequent reason for patients to visit their GP or primary care practitioner, and the predominant reason they would do so is because of increasing difficulty with activities and pain. GPs are often the primary person into many healthcare systems and are typically visited before seeing any other health care practitioner for exercise, diet or surgery. Patients with osteoarthritis often have other serious commodities and the modern health care system typically does not afford long

en

39:31

Should I take this supplement for my osteoarthritis?...

Joint Action ·

2020/11/22

About 70% of people living with osteoarthritis are reported to be taking some form of complementary or alternative medicine for their osteoarthritis. The most common products are fish oil, glucosamine, vitamin D, chondroitin and herbal medicines. This is a very controversial area with differences between what is recommended by physicians, international guidelines, industry and marketing and then ultimately what people actually take for their osteoarthritis. On this episode of Joint Action, we are

en

42:16

What anti-inflammatory should I take for my...

Joint Action ·

2020/11/15

The first line pain relieving medication recommended in most therapeutic guidelines for osteoarthritis is the anti-inflammatory group of medications. They consistently demonstrate modest effects for relieving pain and improving function, pretty much irrespective of the site of osteoarthritis whether that be the hand, knee or hip. There is a huge variety of anti-inflammatories available, different routes of administration including oral and topical, different dosage strengths along with other

en

37:19

Can osteoarthritis be prevented? with Jos Runhaar

Joint Action ·

2020/11/08

Osteoarthritis is an extraordinarily prevalent and disabling disease. The prevalence appears to be increasing, in large part compounded by the ageing of the population but also with major contributions from demographic shifts as it relates to obesity are leading to increasing numbers of people with osteoarthritis. The two biggest risk factors for knee osteoarthritis are obesity and overweight and joint injury. They account for approximately 75% of a person’s likelihood of developing osteoarthritis

en

46:02

Disease Modifying Osteoarthritis Agents with...

Joint Action ·

2020/11/01

Current management approaches for osteoarthritis are usually targeted to symptoms. One way to mitigate the epidemic of osteoarthritis is to modify both its structural progression and symptomatic consequences in tandem a method known as disease modification, as distinct from symptom modification. These could potentially slow the speed of disease progression, completely halted or in an ideal world reverse the disease and regenerate the target tissue. At present, despite a number of positive trials

en

43:10

Osteoarthritis Economics 101 with Elena Losina

Joint Action ·

2020/10/25

The economic burden due to osteoarthritis (OA) is massive and is the result of direct costs to the health care system, indirect costs to individuals living with OA, and the intangible costs of living with a chronic disabling condition. Compared to age and sex-matched peers, OA patients incur higher out of pocket health-related expenditures. People with OA also incur substantial costs due to lost productivity, including both absenteeism (days off work) and presenteeism (reduced self-reported

en

40:23

Hand osteoarthritis with Margreet Kloppenburg

Joint Action ·

2020/10/18

Hand osteoarthritis is a common musculoskeletal disease and associated with hand pain, stiffness, functional limitation and quality of life. For a long time, hand osteoarthritis was a "forgotten disease", resulting in a paucity of good quality clinical trials to help guide the management. However, in more recent years, hand osteoarthritis has gained more attraction and new data to support treatments has become available. On this episode we discuss:what is hand osteoarthritis and which joints are

en

39:16

Foot osteoarthritis with Hylton Menz

Joint Action ·

2020/10/11

Foot osteoarthritis affects one in six adults over the age of 50. It is associated with restricted mobility, disability, poor balance, risk of falling and accounts for a substantial number of healthcare consultations. Due to this, there is an increasing interest in research into foot osteoarthritis and we are learning more about foot osteoarthritis and it's prevalence, risk factors and treatments for this condition. Listen to this episode of Joint Action to learn more about foot osteoarthritis with

en

32:17

Tom's journey with osteoarthritis

Joint Action ·

2020/10/04

On this special episode of Joint Action, we have the privilege of hearing from Tom Buttel and his journey with osteoarthritis. Hear Tom's story and learn how he manages his osteoarthritis to continue living an active lifestyle. We hope that by sharing Tom's story, we are able to motivate and stimulate change in others. On this episode we discuss:the development of Tom's osteoarthritis management/strategies to control the symptoms of osteoarthritisperspectives of different health care providers and

en

59:16

Knee injury and osteoarthritis with Tim Hewett

Joint Action ·

2020/09/27

Approximately 20% of people who go on to develop osteoarthritis do so a result of an injury sustained earlier in their life. The anterior cruciate ligament or ACL, is the most common anatomical structure that accounts for a large proportion of the risk of developing osteoarthritis. Tune into this episode to learn more about ACL injuries and what we can do to reduce joint injury. On this episode we discuss:factors which predict an ACL injuryneuromuscular factors which put a person at risk for

en

36:49

The Osteoarthritis Action Alliance

Joint Action ·

2020/09/20

Dr. Leigh Callahan is the Director of the Osteoarthritis Action Alliance (OAAA). She is also an epidemiologist and outcomes researcher who, for more than 30 years, has worked in musculoskeletal outcomes research.Her research has focused on predictors of outcomes and quality of life in individuals with osteoarthritis (OA) and rheumatoid arthritis (RA), patient-reported outcomes and measurement, physical activity and arthritis, social determinants and health outcomes, health literacy, and

en

38:20

Does race matter?

Joint Action ·

2020/09/13

Dr. Zhang is the Director of Epidemiological and Biostatistical Methods in Rheumatology at Mass General and a Professor in Residence in Medicine at Harvard Medical School. He is a senior epidemiologist with expertise in study design and statistical analysis, and has mentored both MD and PhD trainees and junior faculty for over 30 years.On this episode we discuss: racial differences in the prevalence of osteoarthritis, risk factors for certain populations and much moreResourcesNational Institute of

en

37:56

Implementing dietary change

Joint Action ·

2020/09/06

Rosie Venman is a clinical Dietitian working at Royal North Shore Hospital. Rosie received her Bachelor’s degree in Food Science and Human Nutrition from the University of Newcastle and a Masters in Nutrition and Dietetics from Sydney University.At Royal North Shore Hospital she has been working as the Osteoarthritis Chronic Care Program Dietitian for the last 4 years and has a keen interest in improving weight loss outcomes for this patient group.On this episode we discuss: how to lose weight and

en

159 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown